Lentiviral Vector Patent Portfolio Development
Dec 20, 2006OUTCOME: Sale of portfolio for $12 million
Developed and prosecuted a portfolio of lentiviral gene delivery patents and applications that was sold by her client for $12 million. Press release: http://www.gbpcap.com/ja/companies/gbpip.html
